drugset / Trial / NCT00764582

Ocular Penetration of 1.5% Levofloxacin and 0.5% Moxifloxacin During Corneal Transplant Surgery

NCT00764582

Phase 4 Terminated 60 enrolled Santen Inc. Vistakon Pharmaceuticals · collab
RandomizedParallel-groupSingle-blindBasic science

Summary

Compare the corneal penetration of levofloxacin 1.5% and moxifloxacin 0.5% in patients undergoing penetrating keratoplasty (PK)

Timeline

Start
2008-09
Primary completion
2009-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Levofloxacin Small molecule 1.5 % Topical
Comparator Moxifloxacin Small molecule 0.5 % Topical

Indications

No indication recorded.